Market Overview

Flu Activity Continues to Rise, Related Prescriptions Up 12% from Last Week; Watch CVS, Walgreen

Related CVS
Fast Money Picks For December 23: Gilead Sciences, Starbucks, CVS Health
Bank Of America Raises CVS Health Price Target
Making Money With Charles Payne: 12/5/14 (Fox Business)
Related WAG
Benzinga's Top #PreMarket Losers
Barclays Raises Walgreen Price Target Following Q1 Print
Making Money With Charles Payne: 10/22/14 (Fox Business)

Lazard Capital Market's Tom Galluci issued an update on flu activity Monday morning following a note from December 17th which suggested CVS (NYSE: CVS) and Walgreen (NYSE: WAG) could benefit from increased cases of the virus.

The analyst said flu activity was up 12 percent from last week and up a very concerning 94 percent from the same week last year. Prescriptions for cold, cough and/or flu drugs has surged 61 percent from December 2011.

Galluci believes this increase in activity is likely to have a greater effect on hospital volume metrics rather than earnings as a lower-margin business.

Lazard maintains a Buy rating on CVS and a Neutral rating on Walgreen shares.

Latest Ratings for CVS

DateFirmActionFromTo
Dec 2014SunTrust Robinson HumphreyUpgradesBuy
Dec 2014BarclaysMaintainsOverweight
Dec 2014JP MorganMaintainsOverweight

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings

 

Related Articles (CVS + RAD)

Around the Web, We're Loving...

Get Benzinga's Newsletters